H100 Group (H100) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
23 Nov, 2025Business model and platform
Operates a tech platform connecting health coaches and digital influencers with health and longevity service providers, enabling broader service offerings and streamlined operations.
Generates revenue through a network-effect SaaS model, earning both base fees and a percentage of ecosystem revenue.
Platform supports coaching, health data tracking, wearable integration, telehealth, and medical prescriptions, with future plans for AI, diagnostics, and product matching.
Focuses on recurring revenue streams, including coaching, SaaS, and future AI and subscription services.
Growth strategy and market position
Pursues organic growth by scaling the ecosystem and onboarding more coaches and service providers.
Maintains the option for M&A to consolidate ecosystem partners when strategically beneficial.
Recently listed on the Nordic Growth Markets Stockholm to support growth and acquisition opportunities.
Positioned as a partner, not just a tech tool, aiming to expand distributor and provider offerings.
Financial and operational status
Raised NOK 15 million pre-IPO, providing sufficient funding for at least 18 months at flat revenue growth.
EntireBody, a core asset, generated NOK 16 million in revenue with 50% gross margin.
Actively screens acquisition targets, requiring integration with the platform before acquisition.
Latest events from H100 Group
- Strategic shift to Bitcoin treasury drove rapid asset growth but resulted in large non-cash losses.H100
H2 25/2624 Feb 2026 - Accelerating Bitcoin Treasury and global health initiatives to empower sovereign individuals.H100
Status Update21 Nov 2025 - Strong sales growth and Bitcoin accumulation, but significant non-cash losses and volatility.H100
H1 25/2619 Nov 2025 - Revenue up 166%, net loss reduced, and strategic shift to digital health acquisition underway.H100
H1 24/2513 Jun 2025 - Annual loss deepened on portfolio write-downs; net asset value per share fell 22%.H100
H2 23/2413 Jun 2025 - Acquisition-driven transformation and capital infusion position H100 for digital health growth.H100
H2 24/2511 Jun 2025